A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive

Clinical trial NCT06433921 · RECRUITING

Trial details

NCT number: NCT06433921
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Mild Asthma

Start date: 2024-08-14
Primary completion: 2027-02-26
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.